Tarsus Pharmaceuticals (TARS) Q3 2020 Earnings

25NovConfirmed
Oct 20
Q3 2020
-3.71
-2.64
-1.57
-0.5

Details

Expected EPS
-0.5475
Actual EPS
-0.4989
Surprise EPS
0.05
Surprise Percent
+8.88%

Description

Tarsus Pharmaceuticals (TARS) has reported earnings of -0.4989 per share for Q3 2020.

0 Comments

Share your thoughts